Dan Donovan

RareLife solutions are Dan’s second software and service focused venture. Having observed the often fractured, though always passionate stakeholders in rare diseases, Dan was inspired to create one voice, providing rare disease-specific “guided communities” thoughtfully designed to address several unmet needs while improving disease understanding and accelerating research.

Prior to rareLife and CPP, Dan founded Envision Pharma in 2001, serving as President through June 2011. Dan was the visionary behind the creation and development of Datavision, the market leader in medical publications technology. Envision Pharma was acquired by the United BioSource Corporation (UBC) in April 2008. At UBC, Dan was Senior Vice President of Strategy and Market Development and a member of the Leadership Team.

Dan cut his teeth in the industry at Pfizer serving in a variety of positions of increasing responsibility, ranging from sales to market research and marketing in the US domestic and international market place, culminating in his position as Director and European Team Leader living in Belgium. During his time at Pfizer, he played a pivotal role in the commercialization of some of the pharmaceutical industry's most successful product launches.